[ad_1] Biocon Biologics announced on Saturday, September 28, that the US Food and Drug Administration (US FDA) has completed a Current Good Manufacturing Practice (cGMP) inspection of its Insulins Manufacturing Facility in Johor Bahru, Malaysia. The inspection, which took place between September 17 and September 27, 2024, covered multiple biologics manufacturing units and quality control […]
Headline
Tag: US FDA Biocon Biologics
Back To Top